Cushing's Syndrome
30
1
2
21
Key Insights
Highlights
Success Rate
88% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 40/100
10.0%
3 terminated out of 30 trials
87.5%
+1.0% vs benchmark
17%
5 trials in Phase 3/4
38%
8 of 21 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 21 completed trials
Clinical Trials (30)
Preclinical Study Towards an Immunotherapy in Adrenocortical Carcinoma
Prospective Evaluation of 68Ga-DOTATATE PET/CT, Octreotide and F-DOPA PET Imaging in Ectopic Cushing Syndrome
Defining the Genetic Basis for the Development of Primary Pigmented Nodular Adrenocortical Disease (PPNAD) and the Carney Complex
Contralateral Adrenal Volume Predicts Duration of Postoperative Steroid Replacement Therapy in Non-ACTH-dependent Hypercortisolism
Osilodrostat for the Treatment of Non-Cushing's Disease Cushing's Syndrome
Roll-over Study in Patients With Endogenous Cushing's Syndrome for LCI699
Novel Mediators of the Lipodystrophy and Metabolic Consequences of Cushing's Disease
Retrospective Chart Review Study of Korlym for the Treatment of ACTH Independent Cushing's Syndrome
Effects of Metyrapone in Patients With Endogenous Cushing's Syndrome
Study of Efficacy and Safety of Osilodrostat in Cushing's Syndrome
Diagnostic Performance of Screening Tests for Cushing s Syndrome
Study to Evaluate CORT125134 in Participants With Cushing's Syndrome
Prospective, Open-Label, Multicenter, International Study of Mifepristone for Symptomatic Treatment of Cushing's Syndrome Caused by Ectopic Adrenal Corticotrophin Hormone (ACTH) Secretion
Biomarker Expression in Patients With ACTH-Dependent Cushing's Syndrome Before and After Surgery
In Vivo Study of Interactions Between the Endocannabinoid System and the Corticotropic Axis in Man
Insulin Sensitivity and Substrate Metabolism in Patients With Cushing's Syndrome
Jugular Vein Sampling for Hormone Levels for the Diagnosis of Cushing Syndrome
Saliva Cortisol Measurement as a Screening Test for Suspicious Cushings Syndrome in Children.
A Study to Assess SOM230 in Patients With Pituitary Cushing's Disease
Does Serum-DXM Increase Diagnostic Accuracy of the Overnight DXM Suppression Test in the Work-up of Cushing's Syndrome?